+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pear Therapeutics Inc - Product Pipeline Analysis, 2021 Update

  • ID: 5367370
  • Company Profile
  • June 2021
  • 49 pages
  • GlobalData

FEATURED COMPANIES

  • Click Therapeutics Inc
  • Dthera Sciences
  • Puretech Health Plc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. The company’s lead product candidate reSET for treating substance use disorder. Its product pipeline includes reSET-O for the treatment of opioid use disorder (OUD) in conjunction with opioid replacement therapy; Somryst against chronic insomnia; PEAR-004 targeting schizophrenia; and PEAR-006 for treating multiple sclerosis. The company’s PDT platform is developing therapies targeting Alzheimer's disease, autoimmune disorders, depression, gastrointestinal disorders, migraine and pain. Pear Therapeutics works in collaboration with Center for Technology and Behavioral Health, Dartmouth College, Ehave, Inc, Intellectual Ventures Management LLC, Novartis AG, and others. Pear Therapeutics is headquartered in Boston, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Pear Therapeutics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Click Therapeutics Inc
  • Dthera Sciences
  • Puretech Health Plc
Pear Therapeutics Inc Company Overview
  • Pear Therapeutics Inc Company Snapshot
  • Pear Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Pear Therapeutics Inc - Pipeline Analysis Overview
  • Pear Therapeutics Inc - Key Facts
  • Pear Therapeutics Inc - Major Products and Services
  • Pear Therapeutics Inc Pipeline Products by Development Stage
  • Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status
Pear Therapeutics Inc Pipeline Products Overview
  • Digital Therapeutic - Alzheimer’s Disease
  • Digital Therapeutic - Alzheimer’s Disease Product Overview
  • Digital Therapeutic - Autism Spectrum Disorder
  • Digital Therapeutic - Autism Spectrum Disorder Product Overview
  • Digital Therapeutic - Cardiovascular Disease
  • Digital Therapeutic - Cardiovascular Disease Product Overview
  • Digital Therapeutic - Cognitive Assessment
  • Digital Therapeutic - Cognitive Assessment Product Overview
  • Digital Therapeutic - Epilepsy
  • Digital Therapeutic - Epilepsy Product Overview
  • Digital Therapeutic - Gastrointestinal Disease
  • Digital Therapeutic - Gastrointestinal Disease Product Overview
  • Digital Therapeutic - IBS
  • Digital Therapeutic - IBS Product Overview
  • Digital Therapeutic - Inflammatory conditions
  • Digital Therapeutic - Inflammatory conditions Product Overview
  • Digital Therapeutic - Major Depressive Disorder
  • Digital Therapeutic - Major Depressive Disorder Product Overview
  • Digital Therapeutic - Migraine
  • Digital Therapeutic - Migraine Product Overview
  • Digital Therapeutic - Movement Disorders
  • Digital Therapeutic - Movement Disorders Product Overview
  • Digital Therapeutic - Oncology
  • Digital Therapeutic - Oncology Product Overview
  • Digital Therapeutic - Respiratory
  • Digital Therapeutic - Respiratory Product Overview
  • Digital Therapeutic - Voice Analytics
  • Digital Therapeutic - Voice Analytics Product Overview
  • PEAR-006 - Multiple Sclerosis
  • PEAR-006 - Multiple Sclerosis Product Overview
  • PEAR-006 - Multiple Sclerosis Clinical Trial
  • PEAR-007 - Pain
  • PEAR-007 - Pain Product Overview
  • reCALL
  • reCALL Product Overview
  • reSET-O+
  • reSET-O+ Product Overview
  • reVIVE
  • reVIVE Product Overview
  • Thrive
  • Thrive Product Overview
Pear Therapeutics Inc - Key Competitors

Pear Therapeutics Inc - Key Employees

Pear Therapeutics Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Pear Therapeutics Inc, Recent Developments
  • May 19, 2021: PEAR THERAPEUTICS PRESENTS RESULTS OF TWO ANALYSES SHOWING DECREASES IN HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS USING RESET-O® IN TREATING OPIOID USE DISORDER
  • Apr 06, 2021: Pear Therapeutics enters into agreements with multiple technology companies
  • Feb 10, 2021: Pear Therapeutics to Participate in BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 10, 2021
  • Feb 10, 2021: Pear Therapeutics to Participate in BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
  • Jan 09, 2020: Crossroads treatment centers teams with Pear Therapeutics to bring the first ever digital therapy to an opioid addiction treatment program
  • Dec 17, 2019: Pear Therapeutics announces first patient dosed in part II of Pear-006 feasibility study to treat depressive symptoms in people with multiple sclerosis
  • Oct 30, 2019: Pear Therapeutics announces agreement with Ironwood Pharmaceuticals to evaluate Prescription Digital Therapeutics for patients with GI Indications
  • Oct 17, 2019: Sandoz and Pear Therapeutics announce Pear will solely commercialize reSET and reSET-O
  • Jul 19, 2019: Pear Therapeutics seeks approval for new digital therapeutic Somryst
  • Jul 09, 2019: Winterlight is developing speech-based digital biomarkers to monitor disease progression in patients with FTD in collaboration with Alector
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Pear Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Pear Therapeutics Inc Pipeline Products by Equipment Type
  • Pear Therapeutics Inc Pipeline Products by Indication
  • Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status
  • Pear Therapeutics Inc, Key Facts
  • Pear Therapeutics Inc, Major Products and Services
  • Pear Therapeutics Inc Number of Pipeline Products by Development Stage
  • Pear Therapeutics Inc Pipeline Products Summary by Development Stage
  • Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status
  • Pear Therapeutics Inc Ongoing Clinical Trials Summary
  • Digital Therapeutic - Alzheimer’s Disease - Product Status
  • Digital Therapeutic - Alzheimer’s Disease - Product Description
  • Digital Therapeutic - Autism Spectrum Disorder - Product Status
  • Digital Therapeutic - Autism Spectrum Disorder - Product Description
  • Digital Therapeutic - Cardiovascular Disease - Product Status
  • Digital Therapeutic - Cardiovascular Disease - Product Description
  • Digital Therapeutic - Cognitive Assessment - Product Status
  • Digital Therapeutic - Cognitive Assessment - Product Description
  • Digital Therapeutic - Epilepsy - Product Status
  • Digital Therapeutic - Epilepsy - Product Description
  • Digital Therapeutic - Gastrointestinal Disease - Product Status
  • Digital Therapeutic - Gastrointestinal Disease - Product Description
  • Digital Therapeutic - IBS - Product Status
  • Digital Therapeutic - IBS - Product Description
  • Digital Therapeutic - Inflammatory conditions - Product Status
  • Digital Therapeutic - Inflammatory conditions - Product Description
  • Digital Therapeutic - Major Depressive Disorder - Product Status
  • Digital Therapeutic - Major Depressive Disorder - Product Description
  • Digital Therapeutic - Migraine - Product Status
  • Digital Therapeutic - Migraine - Product Description
  • Digital Therapeutic - Movement Disorders - Product Status
  • Digital Therapeutic - Movement Disorders - Product Description
  • Digital Therapeutic - Oncology - Product Status
  • Digital Therapeutic - Oncology - Product Description
  • Digital Therapeutic - Respiratory - Product Status
  • Digital Therapeutic - Respiratory - Product Description
  • Digital Therapeutic - Voice Analytics - Product Status
  • Digital Therapeutic - Voice Analytics - Product Description
  • PEAR-006 - Multiple Sclerosis - Product Status
  • PEAR-006 - Multiple Sclerosis - Product Description
  • PEAR-006 - Multiple Sclerosis - Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis
  • PEAR-007 - Pain - Product Status
  • PEAR-007 - Pain - Product Description
  • reCALL - Product Status
  • reCALL - Product Description
  • reSET-O+ - Product Status
  • reSET-O+ - Product Description
  • reVIVE - Product Status
  • reVIVE - Product Description
  • Thrive - Product Status
  • Thrive - Product Description
Pear Therapeutics Inc, Key Employees
  • Pear Therapeutics Inc, Other Locations
  • Glossary
List of Figures
  • Pear Therapeutics Inc Pipeline Products by Equipment Type
  • Pear Therapeutics Inc Pipeline Products by Development Stage
  • Pear Therapeutics Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Amylyx Pharmaceuticals Inc
  • Dthera Sciences
  • Click Therapeutics Inc
  • Akili Interactive Labs Inc
  • Puretech Health Plc
Note: Product cover images may vary from those shown
Adroll
adroll